63 related articles for article (PubMed ID: 22133206)
21. Effects of hyperinsulinemia under the euglycemic condition on calcium and phosphate metabolism in non-obese normotensive subjects.
Shimamoto K; Higashiura K; Nakagawa M; Masuda A; Shiiki M; Miyazaki Y; Ise T; Fukuoka M; Hirata A; Iimura O
Tohoku J Exp Med; 1995 Dec; 177(4):271-8. PubMed ID: 8928187
[TBL] [Abstract][Full Text] [Related]
22. Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus.
Katsuki A; Sumida Y; Gabazza EC; Murashima S; Urakawa H; Morioka K; Kitagawa N; Tanaka T; Araki-Sasaki R; Hori Y; Nakatani K; Yano Y; Adachi Y
Eur J Endocrinol; 2002 Jul; 147(1):71-5. PubMed ID: 12088922
[TBL] [Abstract][Full Text] [Related]
23. Effect of acute hyperinsulinemia on magnesium homeostasis in humans.
Xu LH; Maalouf NM
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27546733
[TBL] [Abstract][Full Text] [Related]
24. Palmitoyl-carnitine production by blood cells associates with the concentration of circulating acyl-carnitines in healthy overweight women.
Chondronikola M; Asghar R; Zhang X; Dillon EL; Durham WJ; Wu Z; Porter C; Camacho-Hughes M; Zhao Y; Brasier AR; Volpi E; Sheffield-Moore M; Abate N; Sidossis L; Tuvdendorj D
Clin Nutr; 2017 Oct; 36(5):1310-1319. PubMed ID: 27624997
[TBL] [Abstract][Full Text] [Related]
25. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.
Fonseca VA; Mudaliar S; Schmidt B; Fink LM; Kern PA; Henry RR
Metabolism; 1998 Jun; 47(6):686-9. PubMed ID: 9627367
[TBL] [Abstract][Full Text] [Related]
26. Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes.
Hu X; Ma X; Luo Y; Xu Y; Xiong Q; Pan X; Bao Y; Jia W
Sci Rep; 2016 Oct; 6():34696. PubMed ID: 27698482
[TBL] [Abstract][Full Text] [Related]
27. Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients.
Lormeau B; Aurousseau MH; Valensi P; Paries J; Attali JR
Metabolism; 1997 Sep; 46(9):1074-9. PubMed ID: 9284899
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast Growth Factor 23 and Placental Growth Factor in Patients with Psoriasis and their Relation to Disease Severity.
Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
Ann Clin Lab Sci; 2016; 46(2):174-9. PubMed ID: 27098624
[TBL] [Abstract][Full Text] [Related]
29. Effects of gender and body weight on fibroblast growth factor 23 responsiveness to estimated dietary phosphorus.
Ohta H; Sakuma M; Suzuki A; Morimoto Y; Ishikawa M; Umeda M; Arai H
J Med Invest; 2016; 63(1-2):58-62. PubMed ID: 27040054
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of insulin on aqueous humor flow in patients with type 1 diabetes.
Lane JT; Toris CB; Nakhle SN; Chacko DM; Wang YL; Yablonski ME
Am J Ophthalmol; 2001 Sep; 132(3):321-7. PubMed ID: 11530043
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia.
Biscetti F; Straface G; Pitocco D; Angelini F; Tinelli G; Landolfi R; Flex A
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):4048-4054. PubMed ID: 27775794
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance and metabolic parameters in type 2 diabetic patients.
Metzler W; Fischer S; Köhler C; Pistrosch F; Kindel B; Hanefeld M
Eur J Intern Med; 2002 Mar; 13(2):108-114. PubMed ID: 11893468
[TBL] [Abstract][Full Text] [Related]
33. Changes in postprandial serum fibroblast growth factor 19 in newly diagnosed type-2 diabetic patients and the clinical significance.
Zhao L; Cao Y; Liu Y
J Biol Regul Homeost Agents; 2019; 33(2):385-389. PubMed ID: 30974932
[No Abstract] [Full Text] [Related]
34. Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes.
Komorita Y; Shiroozu A; Nakamura H
J Diabetes Investig; 2023 Aug; 14(8):1009-1010. PubMed ID: 37246726
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of TIO: Is Serum FGF23 Measurement always the Answer?
Ramakrishnan A; Kannan S; Warrier R; Nadig MR; Zaidi SN; Kudari A
Indian J Endocrinol Metab; 2020; 24(2):230-231. PubMed ID: 32699802
[No Abstract] [Full Text] [Related]
36. The Relation of Insulin to Phosphate Metabolism.
Stadie WC
Yale J Biol Med; 1944 May; 16(5):539-59. PubMed ID: 21434171
[No Abstract] [Full Text] [Related]
37. Prediabetes is Characterized by Higher FGF23 Levels and Higher Prevalence of Vitamin D Deficiency Compared to Normal Glucose Tolerance Subjects.
Gateva A; Assyov Y; Tsakova A; Kamenov Z
Horm Metab Res; 2019 Feb; 51(2):106-111. PubMed ID: 30572348
[TBL] [Abstract][Full Text] [Related]
38. The interrelation between FGF23 and glucose metabolism in humans.
Ursem SR; Vervloet MG; Büttler RM; Ackermans MT; Oosterwerff MM; Eekhoff EMV; Lips P; Serlie MJ; la Fleur SE; Heijboer AC
J Diabetes Complications; 2018 Sep; 32(9):845-850. PubMed ID: 29996975
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies.
van der Vaart A; Eelderink C; van Beek AP; Bakker SJL; van Dijk PR; de Borst MH
J Clin Endocrinol Metab; 2023 Sep; 108(10):e971-e978. PubMed ID: 37139691
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
